Up-regulation of bone morphogenetic protein receptor IB by growth factors enhances BMP-2-induced human bone cell functions

Journal of Cellular Physiology

Volumn 209, Issue 3, 2006, Pages 912-922

  Singhatanadgit, Weerachai ^a   Salih, Vehid ^a   Olsen, Irwin ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ALKALINE PHOSPHATASE; BONE MORPHOGENETIC PROTEIN 2; BONE MORPHOGENETIC PROTEIN RECEPTOR; FIBROBLAST GROWTH FACTOR 2; GROWTH FACTOR; MESSENGER RNA; PLATELET DERIVED GROWTH FACTOR AB; SMAD1 PROTEIN; SMAD5 PROTEIN; SMAD6 PROTEIN; SMAD8 PROTEIN; TRANSCRIPTION FACTOR DLX5; TRANSFORMING GROWTH FACTOR BETA1;

ARTICLE; BONE CELL; CELL FUNCTION; CONTROLLED STUDY; ENZYME ACTIVITY; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; OSSIFICATION; OSTEOBLAST; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN INDUCTION; PROTEIN PHOSPHORYLATION; UPREGULATION;

BONE AND BONES; BONE MORPHOGENETIC PROTEIN RECEPTORS, TYPE I; BONE MORPHOGENETIC PROTEINS; CELLS, CULTURED; FIBROBLAST GROWTH FACTOR 2; HUMANS; OSTEOBLASTS; OSTEOGENESIS; PLATELET-DERIVED GROWTH FACTOR; RNA, SMALL INTERFERING; SMAD6 PROTEIN; TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR BETA1; UBIQUITIN-PROTEIN LIGASES; UP-REGULATION;

EID: 33750494938     PISSN: 00219541     EISSN: None     Source Type: Journal    
DOI: 10.1002/jcp.20799     Document Type: Article

References (71)

1. Akiyama S, Katagiri T, Namiki M, Yamaji N, Yamamoto N, Miyama K, Shibuya H, Ueno N, Wozney JM, Suda T. 1997. Constitutively active BMP type I receptors transduce BMP-2 signals without the ligand in C2C12 myoblasts. Exp Cell Res 235:362-369.
2. Amarzguioui M. 2004. Improved siRNA-mediated silencing in refractory adherent cell lines by detachment and transfection in suspension. Biotechniques 36:766-768 , 770.
3. Aoki H, Fujii M, Imamura T, Yagi K, Takehara K, Kato M, Miyazono K. 2001. Synergistic effects of different bone morphogenetic protein type I receptors on alkaline phosphatase induction. J Cell Sci 114:1483-1489.
4. Aubin JE. 1998. Advances in the osteoblast lineage. Biochem Cell Biol 76:899-910.
5. Aubin JE. 2001. Regulation of osteoblast formation and function. Rev Endocr Metab Disord 2:81-94.
6. Balemans W, Van Hul W. 2002. Extracellular regulation of BMP signaling in vertebrates: A cocktail of modulators. Dev Biol 250:231-250.
7. Bessho K, Carnes DL, Cavin R, Chen HY, Ong JL. 1999. BMP stimulation of bone response adjacent to titanium implants in vivo. Clin Oral Implants Res 10:212-218.
8. Boden SD, Rang J, Sandhu H, Heller JG. 2002. Use of recombinant human bone morphogenetic protein-2 to achieve posterolateral lumbar spine fusion in humans: A prospective, randomized clinical pilot trial: 2002 Volvo Award in clinical studies. Spine 27:2662-2673.
9. Canalis E, Economides AN, Gazzerro E. 2003. Bone morphogenetic proteins, their antagonists, and the skeleton. Endocr Rev 24:218-235.
10. Celil AB, Campbell PG. 2005. BMP-2 and insulin-like growth factor-I mediate Osterix (Osx) expression in human mesenchymal stem cells via the MAPK and protein kinase D signaling pathways. J Biol Chem 280:31353-31359.
11. Chan GK, Miao D, Deckelbaum R, Bolivar I, Karaplis A, Goltzman D. 2003. Parathyroid hormone-related peptide interacts with bone morphogenetic protein 2 to increase osteoblastogenesis and decrease adipogenesis in pluripotent C3H10T 1/2 mesenchymal cells. Endocrinology 144:5511-5520.
12. Cheifetz S. 1999. BMP receptors in limb and tooth formation. Crit Rev Oral Biol Med 10:182-198.
13. Chen D, Ji X, Harris MA, Feng JQ, Karsenty G, Celeste AJ, Rosen V, Mundy GR, Harris SE. 1998. Differential roles for bone morphogenetic protein (BMP) receptor type IB and IA in differentiation and specification of mesenchymal precursor cells to osteoblast and adipocyte lineages. J Cell Biol 142:295-305.
14. Chen D, Zhao M, Harris SE, Mi Z. 2004. Signal transduction and biological functions of bone morphogenetic proteins. Front Biosci 9:349-358.
15. Cheng H, Jiang W, Phillips FM, Haydon RC, Peng Y, Zhou L, Luu HH, An N, Breyer B, Vanichakarn P, Szatkowski JP, Park JY, He TC. 2003. Osteogenic activity of the fourteen types of human bone morphogenetic proteins (BMPs). J Bone Joint Surg Am 85-A:1544-1552.
16. Chentoufi J, Hott M, Lamblin D, Buc-Caron MH, Marie PJ, Kellermann O. 1993. Kinetics of in vitro mineralization by an osteogenic clonal cell line (C1) derived from mouse teratocarcinoma. Differentiation 53:181-189.
17. Cochran DL, Rouse CA, Lynch SE, Graves DT. 1993. Effects of platelet-derived growth factor isoforms on calcium release from neonatal mouse calvariae. Bone 14:53-58.
18. Cochran DL, Jones AA, Lilly LC, Fiorellini JP, Howell H. 2000. Evaluation of recombinant human bone morphogenetic protein-2 in oral applications including the use of endosseous implants: 3-year results of a pilot study in humans. J Periodontol 71:1241-1257.
19. Devlin RD, Du Z, Pereira RC, Kimble RB, Economides AN, Jorgetti V, Canalis E. 2003. Skeletal overexpression of noggin results in osteopenia and reduced bone formation. Endocrinology 144:1972-1978.
20. Dewulf N, Verschueren K, Lonnoy O, Moren A, Grimsby S, Vande SK, Miyazono K, Huylebroeck D, ten Dijke P. 1995. Distinct spatial and temporal expression patterns of two type I receptors for bone morphogenetic proteins during mouse embryogenesis. Endocrinology 136:2652-2663.
21. Gazzerro E, Gangji V, Canalis E. 1998. Bone morphogenetic proteins induce the expression of noggin, which limits their activity in cultured rat osteoblasts. J Clin Invest 102:2106-2114.
22. Gerstenfeld LC, Chipman SD, Glowacki J, Lian JB. 1987. Expression of differentiated function by mineralizing cultures of chicken osteoblasts. Dev Biol 122:49-60.
23. Govender S, Csimma C, Genant HK, Valentin-Opran A, Amit Y, Arbel R, Aro H, Atar D, Bishay M, Borner MG, Chiron P, Choong P, Cinats J, Courtenay B, Feibel R, Geulette B, Gravel C, Haas N, Raschke M, Hammacher E, van der Velde D, Hardy P, Holt M, Josten C, Ketterl RL, Lindeque B, Lob G, Mathevon H, McCoy G, Marsh D, Miller R, Munting E, Oevre S, Nordsletten L, Patel A, Pohl A, Rennie W, Reynders P, Rommens PM, Rondia J, Rossouw WC, Daneel PJ, Ruff S, Ruter A, Santavirta S, Schildhauer TA, Gekle C, Schnettler R, Segal D, Seiler H, Snowdowne RB, Stapert J, Taglang G, Verdonk R, Vogels L, Weckbach A, Wentzensen A, Wisniewski T. 2002. Recombinant human bone morphogenetic protein-2 for treatment of open tibial fractures: A prospective, controlled, randomized study of four hundred and fifty patients. J Bone Joint Surg Am 84-A:2123-2134.
24. Hanneken A. 2001. Structural characterization of the circulating soluble FGF receptors reveals multiple isoforms generated by secretion and ectodomain shedding. FEES Lett 489:176-181.
25. Heldin CH, Ostman A, Ronnstrand L. 1998. Signal transduction via platelet-derived growth factor receptors. Biochim Biophys Acta 1378:F79-F113.
26. Horner A, Bord S, Kemp P, Grainger D, Compston JE. 1996. Distribution of platelet-derived growth factor (PDGF) A chain mRNA, protein, and PDGF-alpha receptor in rapidly forming human bone. Bone 19:353-362.
27. Hu Q, Dey AL, Yang Y, Shen Y, Jilani IB, Estey EH, Kantarjian HM, Giles FJ, Albitar M. 2004. Soluble vascular endothelial growth factor receptor 1, and not receptor 2, is an independent prognostic factor in acute myeloid leukemia and myelodysplastic syndromes. Cancer 100:1884-1891.
28. Ikeda T, Takahashi H, Suzuki A, Ueno N, Yokose S, Yamaguchi A, Yoshiki S. 1996. Cloning of rat type I receptor cDNA for bone morphogenetic protein-2 and bone morphogenetic protein-4, and the localization compared with that of the ligands. Dev Dyn 206:318-329.
29. Imamura T, Takase M, Nishihara A, Oeda E, Hanai J, Kawabata M, Miyazono K. 1997. Smad6 inhibits signalling by the TGF-β superfamily. Nature 389:622-626.
30. Ishidou Y, Kitajima I, Obama H, Maruyama I, Murata F, Imamura T, Yamada N, ten Dijke P, Miyazono K, Sakou T. 1995. Enhanced expression of type I receptors for bone morphogenetic proteins during bone formation. J Bone Miner Res 10:1651-1659.
31. Janssens K, ten Dijke P, Janssens S, Van Hul W. 2005. TGF-β1 to the bone. Endocr Rev.
32. Kato T, Kawaguchi H, Hanada K, Aoyama I, Hiyama Y, Nakamura T, Kuzutani K, Tamura M, Kurokawa T, Nakamura K. 1998. Single local injection of recombinant fibroblast growth factor-2 stimulates healing of segmental bone defects in rabbits. J Orthop Res 16:654-659.
33. Kawase T, Okuda K, Saito Y, Yoshie H. 2005. In vitro evidence that the biological effects of platelet-rich plasma on periodontal ligament cells is not mediated solely by constituent transforming-growth factor-β or platelet-derived growth factor. J Periodontol 76:760-767.
34. Kim YJ, Lee MH, Wozney JM, Cho JY, Ryoo HM. 2004. Bone morphogenetic protein-2-induced alkaline phosphatase expression is stimulated by Dlx5 and repressed by Msx2. J Biol Chem 279:50773-50780.
35. Kloen P, Doty SB, Gordon E, Rubel IF, Goumans MJ, Helfet DL. 2002. Expression and activation of the BMP-signaling components in human fracture nonunions. J Bone Joint Surg Am 84-A:1909-1918.
36. Kloen P, Di Paola M, Borens O, Richmond J, Perino G, Helfet DL, Goumans MJ. 2003. BMP signaling components are expressed in human fracture callus. Bone 33:362-371.
37. Kugimiya F, Yano F, Ohba S, Igawa K, Nakamura K, Kawaguchi H, Chung UI. 2005. Mechanism of osteogenic induction by FK506 via BMP/Smad pathways. Biochem Biophys Res Commun 338:872-879.
38. Kuru L, Parkar MH, Griffiths GS, Olsen I. 2001. Flow cytometry analysis of guided tissue regeneration-associated human periodontal cells. J Periodontol 72:1016-1024.
39. Lai CF, Cheng SL. 2002. Signal transductions induced by bone morphogenetic protein-2 and transforming growth factor-β in normal human osteoblastic cells. J Biol Chem 277:15514-15522.
40. Lee KS, Hong SH, Bae SC. 2002. Both the Smad and p38 MAPK pathways play a crucial role in Runx2 expression following induction by transforming growth factor-β and bone morphogenetic protein. Oncogene 21:7156-7163.
41. Li X, Ionescu AM, Schwarz EM, Zhang X, Drissi H, Puzas JE, Rosier RN, Zuscik MJ, O'Keefe RJ. 2003a. Smad6 is induced by BMP-2 and modulates chondrocyte differentiation. J Orthop Res 21:908-913.
42. Li X, Schwarz EM, Zuscik MJ, Rosier RN, Ionescu AM, Puzas JE, Drissi H, Sheu TJ, O'Keefe RJ. 2003b. Retinoic acid stimulates chondrocyte differentiation and enhances bone morphogenetic protein effects through induction of Smad1 and Smad5. Endocrinology 144:2514-2523.
43. Lieberman JR, Daluiski A, Einhorn TA. 2002. The role of growth factors in the repair of bone. Biology and clinical applications. J Bone Joint Surg Am 84-A:1032-1044.
44. Lin X, Zamora PO, Albright S, Glass JD, Pena LA. 2005. Multidomain synthetic peptide B2A2 synergistically enhances BMP-2 in vitro. J Bone Miner Res 20:693-703.
45. Massague J, Chen YG. 2000. Controlling TGF-β signaling. Genes Dev 14:627-644.
46. Miyama K, Yamada G, Yamamoto TS, Takagi C, Miyado K, Sakai M, Ueno N, Shibuya H. 1999. A BMP-inducible gene, dlx5, regulates osteoblast differentiation and mesoderm induction. Dev Biol 208:123-133.
47. Miyazono K, Maeda S, Imamura T. 2005. BMP receptor signaling: Transcriptional targets, regulation of signals, and signaling cross-talk. Cytoki ne Growth Factor Rev 16:251-263.
48. Murakami G, Watabe T, Takaoka K, Miyazono K, Imamura T. 2003. Cooperative inhibition of bone morphogenetic protein signaling by Smurf1 and inhibitory Smads. Mol Biol Cell 14:2809-2817.
49. Nakamura Y, Wakitani S, Nakayama J, Wakabayashi S, Horiuchi H, Takaoka K. 2003. Temporal and spatial expression profiles of BMP receptors and noggin during BMP-2-induced ectopic bone formation. J Bone Miner Res 18:1854-1862.
50. Nakamura Y, Tensho K, Nakaya H, Nawata M, Okabe T, Wakitani S. 2005a. Low dose fibroblast growth factor-2 (FGF-2) enhances bone morphogenetic protein-2 (BMP)-2-induced ectopic bone formation in mice. Bone 36:399-407.
51. Nakamura Y, Wakitani S, Saito N, Takaoka K. 2005b. Expression profiles of BMP-related molecules induced by BMP-2 or -4 in muscle-derived primary culture cells. J Bone Miner Metab 23:426-434.
52. Nakashima M, Reddi AH. 2003. The application of bone morphogenetic proteins to dental tissue engineering. Nat Biotechnol 21:1025-1032.
53. Noth U, Tuli R, Seghatoleslami R, Howard M, Shah A, Hall DJ, Hickok NJ, Tuan RS. 2003. Activation of p38 and Smads mediates BMP-2 effects on human trabecular bone-derived osteoblasts. Exp Cell Res 291:201-211.
54. Dates TW, Xie JF, Clinton S, Hoang AM, Graves DT, Cochran DL. 1998. PDGF-alpha receptor subunit expression down-regulated by 47L-1β in human period-ontal ligament cells. J Dent Res 77:1791-1798.
55. Osyczka AM, Diefenderfer DL, Bhargave G, Leboy PS. 2004. Different effects of BMP-2 on marrow stromal cells from human and rat bone. Cells Tissues Organs 176:109-119.
56. Ovcharenko D, Jarvis R, Hunicke-Smith S, Kelnar K, Brown D. 2005. High-throughput RNAi screening in vitro: From cell lines to primary cells. RNA 11:985-993.
57. Park J, Ries J, Gelse K, Kloss F, von der MK, Wiltfang J, Neukam FW, Schneider H. 2003. Bone regeneration in critical size defects by cell-mediated BMP-2 gene transfer: A comparison of adenoviral vectors and liposomes. Gene Ther 10:1089-1098.
58. Pearson G, Robinson F, Beers GT, Xu BE, Karandikar M, Berman K, Cobb MH. 2001. Mitogen-activated protein (MAP) kinase pathways: Regulation and physiological functions. Endocr Rev 22:153-183.
59. Philip A, Hannah R, O'connor-McCourt M. 1999. Ectodomain cleavage and shedding of the type III transforming growth factor-β receptor in lung membranes effect of temperature, ligand binding and membrane solubilization. Eur J Biochem 261:618-628.
60. Rao M, Sockanathan S. 2005. Molecular mechanisms of RNAi: Implications for development and disease. Birth Defects Res C Embryo Today 75:28-42.
61. Reddi AH. 1998. Role of morphogenetic proteins in skeletal tissue engineering and regeneration. Nat Biotechnol 16:247-252.
62. Sahin U, Weskamp G, Kelly K, Zhou HM, Higashiyama S, Peschon J, Hartmann D, Saftig P, Blobel CP. 2004. Distinct roles for ADAMlO and ADAM17 in ectodomain shedding of six EGFR ligands. J Cell Biol 164:769-779.
63. Sanyal A, Oursler MJ, Clemens VE, Fukumoto T, Fitzsimmons JS, O'Driscoll SW. 2002. Temporal expression patterns of BMP receptors and collagen II (B) during periosteal chondrogenesis. J Orthop Res 20:58-65.
64. Takase M, Imamura T, Sampath TK, Takeda K, Ichijo H, Miyazono K, Kawabata M. 1998. Induction of Smad6 mRNA by bone morphogenetic proteins. Biochem Biophys Res Commun 244:26-29.
65. ten Dijke P, Fu J, Schaap P, Roelen BAJ. 2003. Signal transduction of bone morphogenetic proteins in osteoblast differentiation. J Bone Joint Surg 85:34-38.
66. Webber CA, Chen YY, Hehr CL, Johnston J, McFarlane S. 2005. Multiple signaling pathways regulate FGF-2-induced retinal ganglion cell neurite extension and growth cone guidance. Mol Cell Neurosci 30:37-47.
67. Wu XB, Li Y, Schneider A, Yu W, Rajendren G, Iqbal J, Yamamoto M, Alam M, Brunet LJ, Blair HC, Zaidi M, Abe E. 2003. Impaired osteoblastic differentiation, reduced bone formation, and severe osteoporosis in noggin-overexpressing mice. J Clin Invest 112:924-934.
68. Yabkowitz R, Meyer S, Black T, Elliott G, Merewether LA, Yamane HK. 1999. Inflammatory cytokines and vascular endothelial growth factor stimulate the release of soluble tie receptor from human endothelial cells via metalloprotease activation. Blood 93:1969-1979.
69. Yamaguchi A, Komori T, Suda T. 2000. Regulation of osteoblast differentiation mediated by bone morphogenetic proteins, hedgehogs, and Cbfa1. Endocr Rev 21:393-411.
70. Yamamoto N, Akiyama S, Katagiri T, Namiki M, Kurokawa T, Suda T. 1997. Smad1 and 7mad5 act downstream of intracellular signalings of BMP-2 that inhibits myogenic differentiation and induces osteoblast differentiation in C2C12 myoblasts. Biochem Biophys Res Commun 238:574-580.
71. Zhao M, Qiao M, Harris SE, Oyajobi BO, Mundy GR, Chen D. 2004. Smurf1 inhibits osteoblast differentiation and bone formation in vitro and in vivo. J Biol Chem 279:12854-12859.